CERS2 Suppresses Tumor Cell Invasion and is Associated with Decreased V-ATPase and MMP-2/MMP-9 Activities in Breast Cancer

Journal of Cellular Biochemistry

Volumn 116, Issue 4, 2015, Pages 502-513

  Fan, Shao Hua ^a   Wang, Yan Yan ^b   Lu, Jun ^a   Zheng, Yuan Lin ^a   Wu, Dong Mei ^a   Zhang, Zi Feng ^a   Shan, Qun ^a   Hu, Bin ^a   Li, Meng Qiu ^a   Cheng, Wei ^c  

^a JIANGSU NORMAL UNIVERSITY   (China)

^b Oriental People's Hospital of Xuzhou   (China)

^c CHINA UNIVERSITY OF MINING AND TECHNOLOGY   (China)

Author keywords

BREAST CANCER; CERS2; INVASION; V ATPASE

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CERAMIDE SYNTHASE 2; ENZYME; GELATINASE A; GELATINASE B; MESSENGER RNA; UNCLASSIFIED DRUG; VACUOLAR H ATPASE; CERS2 PROTEIN, HUMAN; MEMBRANE PROTEIN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SPHINGOSINE ACYLTRANSFERASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CANCER; CELL INVASION; CELL MIGRATION; CELL PH; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STABLE TRANSFECTION; SUPERNATANT; TUMOR CELL; TUMOR INVASION; WESTERN BLOTTING; BREAST TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; SPHINGOSINE N-ACYLTRANSFERASE; TUMOR SUPPRESSOR PROTEINS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84941038853     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24978     Document Type: Article

References (38)

1. Capecci J, Forgac M,. 2013. The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells. J Biol Chem 288: 32731-32741.
2. Cardoso AP, Pinto ML, Pinto AT, Oliveira MI, Pinto MT, Gonçalves R, Relvas JB, Figueiredo C, Seruca R, Mantovani A, Mareel M, Barbosa MA, Oliveira MJ,. 2014. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y1086, c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity. Oncogene 33: 2123-2133.
3. Chung C, Mader CC, Schmitz JC, Atladottir J, Fitchev P, Cornwell ML, Koleske AJ, Crawford SE, Gorelick F,. 2011. The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer. Lab Invest 91: 732-743.
4. +-ATPase-mediated acidification for Wnt signaling. Science 327: 459-463.
5. de Lucca Camargo L, Babelova A, Mieth A, Weigert A, Mooz J, Rajalingam K, Heide H, Wittig I, Lopes LR, Brandes RP,. 2013. Endo-PDI is required for TNFα-induced angiogenesis. Free Radic Biol Med 65: 1398-1407.
6. Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D, Wang H, Gu J, Yao M, Li J, Tu H, He X,. 2010. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 12: 390-399.
7. Dunne PD, McArt DG, Blayney JK, Kalimutho M, Greer S, Wang T, Srivastava S, Ong CW, Arthur K, Loughrey M, Redmond K, Longley DB, Salto-Tellez M, Johnston PG, Van Schaeybroeck S,. 2014. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer. Clin Cancer Res 20: 164-175.
8. Egeblad M, Werb Z,. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
9. Erez-Roman R, Pienik R, Futerman AH,. 2010. Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression. Biochem Biophys Res Commun 391: 219-223.
10. Fagan-Solis KD, Schneider SS, Pentecost BT, Bentley BA, Otis CN, Gierthy JF, Arcaro KF,. 2013. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line. J Cell Biochem 114: 1385-1394.
11. +-ATPase as a new strategy against cancer. Cancer Res 67: 10627-10630.
12. Fan S, Niu Y, Tan N, Wu Z, Wang Y, You H, Ke R, Song J, Shen Q, Wang W, Yao G, Shu H, Lin H, Yao M, Zhang Z, Gu J, Qin W,. 2013. LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump. Oncogene 32: 1682-1690.
13. Fang M, Yuan JP, Peng CW, Pang DW, Li Y,. 2013. Quantum dots-based in situ molecular imaging of dynamic changes of collagen IV during cancer invasion. Biomaterials 34: 8708-8717.
14. Fitzgerald S, Sheehan KM, O'Grady A, Kenny D, O'Kennedy R, Kay EW, Kijanka G,. 2013. Increased ceramide synthase 5 expression is associated with lymphovascular invasion, metastasis and poor survival in colorectal cancer. Cancer Res 73 (8 Suppl).
15. + ATPase. Oncogene 1.DOI: 10.1038/onc.2013.403.[in press].
16. + ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. Int J Cancer 133: 843-854.
17. Jurmeister S1, Baumann M, Balwierz A, Keklikoglou I, Ward A, Uhlmann S, Zhang JD, Wiemann S, Sahin Ö,. 2012. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol Cell Biol 32: 633-651.
18. Kessenbrock K, Plaks V, Werb Z,. 2010. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
19. Koybasi S, Senkal CE, Sundararaj K, Spassieva S, Bielawski J, Osta W, Day TA, Jiang JC, Jazwinski SM, Hannun YA, Obeid LM, Ogretmen B,. 2004. Defects in cell growth regulation by C18: 0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Cell Biochem 279: 44311-44319.
20. Kummer NT, Nowicki TS, Azzi JP, Reyes I, Iacob C, Xie S, Swati I, Darzynkiewicz Z, Gotlinger KH, Suslina N, Schantz S, Tiwari RK, Geliebter J,. 2012. Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. J Cell Biochem 113: 1998-2008.
21. Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill AH, Jr, Futerman AH,. 2008. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem 283: 5677-5684.
22. Lu P, Weaver VM, Werb Z,. 2012. The extracellular matrix: A dynamic niche in cancer progression. J Cell Biol 196: 395-406.
23. Lu X, Qin W, Li J, Tan N, Pan D, Zhang H, Xie L, Yao G, Shu H, Yao M, Wan D, Gu J, Yang S,. 2005. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res 65: 6843-6849.
24. Michel V, Licon-Munoz Y, Trujillo K, Bisoffi M, Parra KJ,. 2013. Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion. Int J Cancer 132: E1-10.
25. Niikura K,. 2007. Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis. Cancer Chemother Pharmacol 60: 555-562.
26. Pan H, Qin WX, Huo KK, Wan DF, Yu Y, Xu ZG, Hu QD, Gu KT, Zhou XM, Jiang HQ, Zhang PP, Huang Y, Li YY, Gu JR,. 2001. Cloning, mapping, and characterization of a human homologue of the yeast longevity assurance gene LAG1. Genomics 77: 58-64.
27. Pérez-Sayáns M, García-García A, Reboiras-Lõpez MD, Gándara-Vila P,. 2009. Role of V-ATPases in solid tumors: Importance of the subunit C (Review). Int J Oncol 34: 1513-1520.
28. Phromnoi K, Yodkeeree S, Anuchapreeda S, Limtrakul P,. 2009. Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacol Sin 30: 1169-1176.
29. Pons DG, Nadal-Serrano M, Blanquer-Rossello MM, Sastre-Serra J, Oliver J, Roca P,. 2014. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. J Cell Biochem 115: 949-958.
30. Rofstad EK, Mathiesen B, Kindem K, Galappathi K,. 2006. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 66: 6699-6707.
31. +-ATPases at the plasma membrane regulate pH and cell migration in microvascular endothelial cells. Am J Physiol Heart Circ Physiol 291: H1147-H1157.
32. Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, Grösch S, Geisslinger G, Holtrich U, Karn T, Kaufmann M,. 2008. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat 112: 41-52.
33. Schiffmann S, Sandner J, Birod K, Wobst I, Angioni C, Ruckhäberle E, Kaufmann M, Ackermann H, Lötsch J, Schmidt H, Geisslinger G, Grösch S,. 2009. Ceramide synthases and ceramide levels are increased in breast cancer tissue. Carcinogenesis 30: 745-752.
34. +-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 286: C1443-C1452.
35. Siegel R, Naishadham D, Jemal A,. 2013. Cancer statistics. CA Cancer J Clin 63: 11-30.
36. Wang YY, Gao LY, Zhao YH, Li JY, Luo Q, Fan SH,. 2013. Expression of CERS2 in invasive breast cancer tissues and its clinical significance. Zhonghua Bing Li Xue Za Zhi 42: 267-268.
37. Wiedmann RM, von Schwarzenberg K, Palamidessi A, Schreiner L, Kubisch R, Liebl J, Schempp C, Trauner D, Vereb G, Zahler S, Wagner E, Müller R, Scita G, Vollmar AM,. 2012. The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1. Cancer Res 72: 5976-5987.
38. Yu W, Wang L, Wang Y, Xu X, Zou P, Gong M, Zheng J, You J, Wang H, Mei F, Pei F,. 2013. A novel tumor metastasis suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through its homeodomain 114: 570-583.